WASHINGTON, D.C. – Recently, U.S. Senator Shelley Moore Capito (R-W.Va.) announced her co-sponsorship of the Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act, legislation that would cap the monthly out-of-pocket cost of insulin at $35 for Americans on private and employer-sponsored insurance and create a pilot program to provide insulin at the same cost to Americans without insurance. The legislation is led by U.S. Senators Jeanne Shaheen (D-N.H.) and Susan Collins (R-Maine).
“For years, West Virginia has been deeply impacted by diabetes and the rising cost of insulin,” Senator Capito said. “By limiting out-of-pocket insulin costs for individuals with private or employer-sponsored insurance, we can bring immediate financial relief to millions of Americans—including many West Virginians.”
BACKGROUND:
The INSULIN Act would directly address issues in the insulin market causing high list prices, while simultaneously extending vital patient protections, fostering competition and broadening access to needed insulin products. Specifically, the INSULIN Act:
Full text of the legislation can be found here.
# # #